STOCK TITAN

Photronics Inc 10-Q Filings

PLAB NASDAQ

Every 10-Q that Photronics Inc (PLAB) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow PLAB and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PLAB filings page.

Rhea-AI Summary

Photronics, Inc. (PLAB) reported modest top-line growth but significantly stronger profitability for the quarter and nine months ended August 2, 2026. Quarterly revenue rose to $216.0 million from $210.4 million a year earlier, while net income attributable to shareholders increased to $28.9 million from $22.9 million, with diluted EPS of $0.49 versus $0.39.

For the first nine months of fiscal 2026, revenue grew to $651.1 million from $633.5 million, but gross margin narrowed to 33.2% from 35.4% due to higher materials, labor, and manufacturing costs. Despite this pressure, net income attributable to shareholders climbed to $103.3 million from $74.6 million, and diluted EPS rose to $1.76 from $1.23, helped by higher high-end photomask demand and favorable foreign-currency impacts.

Operating cash flow strengthened to $220.6 million for the nine-month period, up from $160.0 million, supporting increased capital expenditures of $130.4 million focused on high-end and mainstream capacity. Photronics ended the quarter with $549.5 million in cash and cash equivalents and minimal debt of $3.9 million, and disclosed ongoing investments in advanced IC and FPD photomask technologies and a remaining $27.6 million share repurchase authorization.

Rhea-AI Summary

Photronics reported Q2 FY26 results showing sharply higher profit on roughly flat sales. Revenue was $209.9 million, down slightly from $211.0 million a year earlier, but net income attributable to shareholders jumped to $31.4 million from $8.9 million, lifting diluted EPS to $0.54 from $0.15.

Gross margin fell to 31.3% from 36.9% as labor, materials, and manufacturing costs increased, while FPD revenue grew 13.3% and IC revenue declined 5.4%. Foreign currency impacts swung to a $7.9 million gain from a $31.1 million loss, boosting other income.

For the first six months, revenue rose to $435.0 million from $423.1 million and diluted EPS increased to $1.27 from $0.84. Photronics held $511.5 million in cash and cash equivalents and plans about $330 million of FY26 capital expenditures, with $27.6 million still authorized for share repurchases.

Rhea-AI Summary

Photronics, Inc. reported higher results for the quarter ended February 1, 2026. Revenue rose to $225.1 million, up from $212.1 million, driven mainly by stronger demand for high-end integrated circuit photomasks in Asia and higher mainstream flat-panel display business in China.

Gross margin held at 35.0%, while net income attributable to shareholders was $42.9 million, essentially flat versus $42.9 million a year ago, as higher operating costs and lower foreign currency gains offset revenue growth. Diluted EPS was $0.74, compared with $0.68.

The company generated $97.3 million of operating cash flow and ended the quarter with $544.1 million in cash and cash equivalents, up from $492.3 million. Capital expenditures were $47.6 million in the quarter, and management expects about $330 million of capex in fiscal 2026, focused mainly on high-end and mainstream capacity in Asia and the U.S.

Photronics did not repurchase shares in the quarter and still has $27.6 million remaining under its authorization. The PDMCX joint venture in China continues to be consolidated, contributing to noncontrolling interests’ net income of $17.2 million. The balance sheet remains lightly levered, with total debt of $21 thousand and total equity of $1.65 billion.

Rhea-AI Summary

Photronics, Inc. (PLAB) filed its Form 10-Q for the quarter ended August 3, 2025, presenting condensed consolidated interim financial statements and MD&A. The company reported cash and cash equivalents of $479.5 million, down from $598.5 million at October 31, 2024, with $416.1 million held by foreign subsidiaries (including $328.2 million in joint ventures). Photronics repurchased 5.0 million shares for $97.4 million year-to-date and completed an additional 1.2 million shares for $20.7 million in the quarter; $27.6 million remains available under its repurchase authorization.

The company expects fiscal 2025 capital expenditures of about $200 million, had outstanding capital commitments of $147.2 million, and estimates funding of approximately $154.8 million of committed obligations over the next twelve months. Photronics consolidated results include its China joint venture (PDMCX) and reported decreased net income attributable to noncontrolling interests versus prior periods. Key risks and exposures disclosed include a $69.7 million pre-tax potential loss from a 10% adverse foreign currency move and ongoing evaluation of recent U.S. tax law changes.